RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+8.95%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$3B
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$79.3M |
| 2 |
Blackstone
BX
|
+$58.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$41.8M |
| 4 |
Palantir
PLTR
|
+$39.1M |
| 5 |
Snowflake
SNOW
|
+$25.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$217M |
| 2 |
Microsoft
MSFT
|
+$173M |
| 3 |
Linde
LIN
|
+$131M |
| 4 |
Amazon
AMZN
|
+$98M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$86.8M |
Sector Composition
| 1 | Technology | 23.36% |
| 2 | Financials | 14.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Greenlight Captial
GLRE
$424M
| $368K | ﹤0.01% |
40,278
-6,122
| -13% | -$55.9K |
|
2702
Avita Medical
RCEL
$113M
| $368K | ﹤0.01% |
+17,911
| New | +$368K |
|
2703
Atomera
ATOM
$101M
| $367K | ﹤0.01% |
17,132
+3,029
| +21% | +$64.9K |
|
2704
Olema Pharmaceuticals
OLMA
$536M
| $367K | ﹤0.01% |
13,134
+2,168
| +20% | +$60.6K |
|
2705
Stereotaxis
STXS
$256M
| $367K | ﹤0.01% |
38,110
+3,551
| +10% | +$34.2K |
|
2706
Spyre Therapeutics
SYRE
$977M
| $367K | ﹤0.01% |
2,107
+254
| +14% | +$44.2K |
|
2707
Applied Therapeutics
APLT
$64M
| $366K | ﹤0.01% |
17,611
+1,869
| +12% | +$38.8K |
|
2708
Evolus
EOLS
$475M
| $366K | ﹤0.01% |
28,951
+4,572
| +19% | +$57.8K |
|
2709
Limoneira
LMNR
$269M
| $366K | ﹤0.01% |
20,837
-2,369
| -10% | -$41.6K |
|
2710
Rush Enterprises Class B
RUSHB
$4.4B
| $365K | ﹤0.01% |
14,337
-2,204
| -13% | -$56.1K |
|
2711
UroGen Pharma
URGN
$884M
| $365K | ﹤0.01% |
23,903
-2,675
| -10% | -$40.8K |
|
2712
AgEagle Aerial Systems
UAVS
$69.8M
| $363K | ﹤0.01% |
+69
| New | +$363K |
|
2713
Citius Pharmaceuticals
CTXR
$20.6M
| $362K | ﹤0.01% |
+4,161
| New | +$362K |
|
2714
Cue Biopharma
CUE
$58.6M
| $361K | ﹤0.01% |
31,014
-2,078
| -6% | -$24.2K |
|
2715
Spruce Power Holding Corp
SPRU
$28.7M
| $361K | ﹤0.01% |
+5,415
| New | +$361K |
|
2716
Aveanna Healthcare
AVAH
$1.73B
| $360K | ﹤0.01% |
+29,109
| New | +$360K |
|
|
KNTE
2717
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $360K | ﹤0.01% |
15,455
+3,758
| +32% | +$87.5K |
|
|
LTRPA
2718
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $360K | ﹤0.01% |
88,473
-34,431
| -28% | -$140K |
|
2719
Puma Biotechnology
PBYI
$229M
| $358K | ﹤0.01% |
39,041
-2,448
| -6% | -$22.4K |
|
2720
Tonix Pharmaceuticals
TNXP
$237M
| $358K | ﹤0.01% |
+1
| New | +$358K |
|
2721
Commercial Vehicle Group
CVGI
$70.3M
| $356K | ﹤0.01% |
+33,464
| New | +$356K |
|
2722
iShares Russell 2000 Value ETF
IWN
$11.8B
| $355K | ﹤0.01% |
+2,140
| New | +$355K |
|
|
NAPA
2723
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $355K | ﹤0.01% |
+16,103
| New | +$355K |
|
|
YELL
2724
DELISTED
Yellow Corporation Common Stock
YELL
| $354K | ﹤0.01% |
+54,441
| New | +$354K |
|
|
SYRS
2725
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $353K | ﹤0.01% |
6,472
+1,802
| +39% | +$98.3K |
|